Buerger's disease, also known as thromboangiitis obliterans, is a rare condition that primarily affects young to middle-aged male smokers. The veins and arteries of the extremities constrict or block ...
DelveInsight’s, “Buerger’s Disease - Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Buerger’s Disease pipeline landscape. It covers the ...
Buerger's disease, also known as thromboangiitis obliterans (TAO), is a non-atherosclerotic, inflammatory occlusive disease that predominantly affects small- and medium-sized arteries and veins of the ...
Ambulero Inc., a spinout from the University of Miami Miller School of Medicine, has received a positive response from a type B pre-IND meeting with the FDA on the development of AMB-301 as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback